Malate-aspartate shuttle
Malate-aspartate shuttle is a biochemical system that occurs in the cells of many organisms, including humans. It plays a crucial role in the metabolism of glucose, facilitating the transfer of NADH (nicotinamide adenine dinucleotide (reduced form)) from the cytoplasm into the mitochondria. This process is essential for the production of ATP (adenosine triphosphate), the energy currency of the cell, through oxidative phosphorylation.
Function[edit | edit source]
The primary function of the malate-aspartate shuttle is to transport NADH, generated in the cytoplasm by glycolytic breakdown of glucose, into the mitochondria. Since the mitochondrial membrane is impermeable to NADH, this shuttle provides an indirect pathway. Inside the mitochondria, NADH is used in the electron transport chain to generate ATP. The shuttle operates in tissues with high metabolic rates such as the heart, liver, and kidney.
Mechanism[edit | edit source]
The shuttle mechanism involves several steps and key enzymes, including malate dehydrogenase and aspartate aminotransferase. The process begins with the reduction of oxaloacetate to malate by malate dehydrogenase in the cytoplasm. Malate can then cross the mitochondrial membrane. Once inside the mitochondria, malate is oxidized back to oxaloacetate, producing NADH in the process.
Simultaneously, oxaloacetate is transaminated to aspartate by aspartate aminotransferase. Aspartate crosses back into the cytoplasm and is converted back to oxaloacetate, completing the cycle. This series of reactions effectively moves reducing equivalents in the form of NADH into the mitochondria for ATP production, while maintaining the NAD+/NADH balance in the cytoplasm.
Clinical Significance[edit | edit source]
Alterations in the malate-aspartate shuttle can have significant metabolic consequences. Because this shuttle plays a key role in energy production, its dysfunction can lead to a decrease in ATP generation, affecting tissues with high energy demands. This can contribute to various metabolic disorders and has been implicated in the pathology of diseases such as diabetes mellitus and ischemic heart disease.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD